mRNA vaccines — a new era in vaccinology

Pardi, Norbert, Hogan, Michael J., Porter, Frederick W., Weissman, Drew·2018·Nature Reviews Drug Discovery
DOI 10.1038/nrd.2017.243

Cited by (1,011)

Items 601–700 of 1,011

  1. The safety profile of COVID-19 vaccinations in the United States
    Amninder Singh, Ratesh Khillan, Yogendra Mishra, Sumit S. Khurana · 2021 · American Journal of Infection Control
  2. Cancer vaccines: past, present and future; a review article
    Eddie Grimmett, Bayan A. Al-Share, Mohamad Basem Alkassab, Ryan Weng Zhou, Advait Desai, Mir Munir A. Rahim, Indryas Woldie · 2022 · Discover Oncology
  3. Nanomaterials for mRNA ‐based therapeutics: Challenges and opportunities
    Defeng Li, Qisong Liu, Meifeng Yang, Haoming Xu, Min‐zheng Zhu, Yuan Zhang, Jing Xu, Cheng‐mei Tian, Jun Yao, Lisheng Wang et al. · 2023 · Bioengineering & Translational Medicine
  4. An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection
    Brooke A Bollman, Naveen Nunna, Kapil Bahl, Chiaowen Joyce Hsiao, Hamilton Bennett, Scott Butler, Bryant M. Foreman, Katherine E. Burgomaster, Maya Aleshnick, Wing‐Pui Kong et al. · 2023 · npj Vaccines
  5. Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer
    Dequan Liu, Xiangyu Che, Xiaoxi Wang, Chuanyu Ma, Guangzhen Wu · 2023 · Pharmaceuticals
  6. Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans
    Stephen John Kent, Shiyao Li, Thakshila H. Amarasena, Arnold Reynaldi, Wen Shi Lee, Michael G. Leeming, David H. O’Connor, Julie T. Nguyen, Helen E. Kent, Frank Caruso et al. · 2024 · ACS Nano
  7. Recent Advances and Prospects in RNA Drug Development
    Hidenori Tani · 2024 · International Journal of Molecular Sciences
  8. Optimization of an mRNA vaccine assisted with cyclodextrin-polyethyleneimine conjugates
    Lu Tan, Tao Zheng, Man Li, Xiaofang Zhong, Yao Tang, Ming Qin, Xun Sun · 2020 · Drug Delivery and Translational Research
  9. Engineering Antiviral Vaccines
    Xingwu Zhou, Xing Jiang, Moyuan Qu, George E. Aninwene, Vadim Jucaud, James Jaehyun Moon, Zhen Gu, Wujin Sun, Ali Khademhosseini · 2020 · ACS Nano
  10. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases
    Victoria Furer, Christien Rondaan, Nancy Agmon‐Levin, Sander van Assen, Marc Bijl, Meliha Crnkic Kapetanovic, Annette Ladefoged de Thurah, Ulf Müeller-Ladner, Daphna Paran, Karen Ingrid Schreiber et al. · 2021 · RMD Open
  11. Enhancing therapeutic performance of personalized cancer vaccine via delivery vectors
    Tong Ye, Feng Li, Guanghui Ma, Wei Wei · 2021 · Advanced Drug Delivery Reviews
  12. In vivo fate and intracellular trafficking of vaccine delivery systems
    Jaiwoo Lee, Dongyoon Kim, Junho Byun, Yina Wu, Jin-Won Park, Yu‐Kyoung Oh · 2022 · Advanced Drug Delivery Reviews
  13. Esterase‐Labile Quaternium Lipidoid Enabling Improved mRNA‐LNP Stability and Spleen‐Selective mRNA Transfection
    Runnan Zhang, Shiqun Shao, Ying Piao, Jiajia Xiang, Xuyong Wei, Zhen Zhang, Zhuxian Zhou, Jianbin Tang, Nasha Qiu, Xiao Xu et al. · 2023 · Advanced Materials
  14. Functional Nanoparticles with a Reducible Tetrasulfide Motif to Upregulate mRNA Translation and Enhance Transfection in Hard‐to‐Transfect Cells
    Yue Wang, Jie Tang, Yannan Yang, Hao Song, Jianye Fu, Zhengying Gu, Chengzhong Yu · 2019 · Angewandte Chemie International Edition
  15. D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
    Drew Weissman, Mohamad‐Gabriel Alameh, Thushan I. de Silva, Paul Collini, Hailey R. Hornsby, Rebecca L. Brown, Celia C. LaBranche, Robert J. Edwards, Laura L. Sutherland, Sampa Santra et al. · 2020 · medRxiv
  16. Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States
    Montano, Diego · 2022 · Frontiers in Public Health
  17. Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy
    Tuan Hiep Tran, Thi Thu Phuong Tran, Duy Hieu Truong, Hanh Thuy Nguyen, Tung Thanh Pham, Chul Soon Yong, Jong Oh Kim · 2019 · Acta Biomaterialia
  18. Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development
    Daniela Cornelia Călina, Chandan Kumar Sarkar, Andreea Letiția Arsene, Bahare Salehi, Anca Oana Docea, Milon Mondal, Muhammad Torequl Islam, Alireza Zali, Javad Sharifi‐Rad · 2020 · Immunologic Research
  19. The find of COVID-19 vaccine: Challenges and opportunities
    Marwan ElBagoury, Mahmoud M. Tolba, Hebatallah Ahmed Nasser, Abdul Jabbar, Ahmed M. Elagouz, Yahia Aktham, Amy Hutchinson · 2020 · Journal of Infection and Public Health
  20. Delivery of therapeutic oligonucleotides in nanoscale
    Lei Wu, Wenhui Zhou, Lihua Lin, Anhong Chen, Jing Chun Feng, Xiangmeng Qu, Hongbo Zhang, Jun Yue · 2021 · Bioactive Materials
  21. Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine
    Rebecca J. Loomis, Anthony T. DiPiazza, Samantha Falcone, Tracy J. Ruckwardt, Kaitlyn M. Morabito, Olubukola M. Abiona, Lauren A. Chang, Ria T. Caringal, Vladimir Presnyak, Elisabeth Narayanan et al. · 2021 · Frontiers in Immunology
  22. mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles
    Andreas Ouranidis, Theofanis Vavilis, Evdokia Mandala, Christina Davidopoulou, Εleni Stamoula, Catherine K. Markopoulou, Anna Karagianni, Kyriakos Kachrimanis · 2021 · Biomedicines
  23. Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors
    Judith Stickdorn, Lara Stein, Danielle Arnold-Schild, Jennifer Hahlbrock, Carolina Medina‐Montano, Joschka Bartneck, Tanja Ziß, Evelyn Montermann, Cinja Kappel, Dominika Hobernik et al. · 2022 · ACS Nano
  24. Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics
    Pieter Vervaeke, Sven Even Borgos, Niek N. Sanders, Francis Combes · 2022 · Advanced Drug Delivery Reviews
  25. Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
    Si’Ana A. Coggins, Eric D. Laing, Cara H. Olsen, Emilie Goguet, Matthew S. Moser, Belinda M Jackson-Thompson, Emily C Samuels, Simon D. Pollett, David R. Tribble, Julian Davies et al. · 2021 · Open Forum Infectious Diseases
  26. TLRs: Innate Immune Sentries against SARS-CoV-2 Infection
    Stefania Mantovani, Barbara Oliviero, Stefania Varchetta, Alessandra Renieri, Mario Umberto Mondelli · 2023 · International Journal of Molecular Sciences
  27. Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines
    Sonal Gupta, Sabine Pellett · 2023 · Toxins
  28. mRNA vaccine quality analysis using RNA sequencing
    Helen M. Gunter, Senel Idrisoglu, Swati Singh, Dae Jong Han, Emily Ariens, Jonathan R. Peters, Ted Wong, Seth W. Cheetham, Jun Xu, Subash Kumar Rai et al. · 2023 · Nature Communications
  29. Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design
    Bruna Clemente, Maxime Denis, Camila Pedroso Silveira, Francesca Schiavetti, Michela Brazzoli, Daniela Stranges · 2023 · Frontiers in Immunology
  30. Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach
    Rachel E. Young, Katherine M. Nelson, Samuel I. Hofbauer, Tara Vijayakumar, Mohamad‐Gabriel Alameh, Drew Weissman, Charalampos Papachristou, Jason P. Gleghorn, Rachel Riley · 2023 · Bioactive Materials
  31. Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development
    Thomas Vallet, Marco Vignuzzi · 2025 · Viruses
  32. In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies
    Ami R. Patel, Mamadou A. Bah, David B. Weiner · 2020 · BioDrugs
  33. Recent advances in mRNA vaccine delivery
    Lu Tan, Xun Sun · 2018 · Nano Research
  34. Delivery routes matter: Safety and efficacy of intratumoral immunotherapy
    Emily De Lombaerde, Olivier De Wever, Bruno G. De Geest · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  35. Targeting the Tumor Microenvironment for Improving Therapeutic Effectiveness in Cancer Immunotherapy: Focusing on Immune Checkpoint Inhibitors and Combination Therapies
    I‐Tsu Chyuan, Ching‐Liang Chu, Ping‐Ning Hsu · 2021 · Cancers
  36. Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery
    Roy van der Meel, Sam Chen, Josh Zaifman, Jayesh A. Kulkarni, Xu Ran S. Zhang, Ying K. Tam, Marcel B. Bally, Raymond Michel Schiffelers, Marco A. Ciufolini, Pieter R. Cullis et al. · 2021 · Small
  37. Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines
    Dixita Ishani Viswanath, Hsuan‐Chen Liu, David P. Huston, Corrine Ying Xuan Chua, Alessandro Grattoni · 2021 · Biomaterials
  38. mRNA vaccines: The future of prevention of viral infections?
    Piotr Rzymski, Agnieszka Szuster‐Ciesielska, Tomasz Dzieciątkowski, Willis Gwenzi, Andrzej Fal · 2023 · Journal of Medical Virology
  39. An in vitro-transcribed circular RNA targets the mitochondrial inner membrane cardiolipin to ablate EIF4G2+/PTBP1+ pan-adenocarcinoma
    Zunyong Feng, Xuanbo Zhang, Jing Zhou, Qiang Li, Liuxi Chu, Guangfu Di, Zhengyuan Xu, Qun Chen, Ming Wang, Xiaochun Jiang et al. · 2023 · Nature Cancer
  40. Vaccine adjuvants: current status, research and development, licensing, and future opportunities
    Ying Cui, Megan Ho, Yongjie Hu, Yuan Shi · 2024 · Journal of Materials Chemistry B
  41. Immunogenicity and Protection Efficacy of a Naked Self-Replicating mRNA-Based Zika Virus Vaccine
    Zifu Zhong, João Paulo Portela Catani, Séan Mc Cafferty, Liesbeth Couck, Wim Van Den Broeck, Nina Gorlé, Roosmarijn E. Vandenbroucke, Bert Devriendt, Sebastian Ulbert, Lieselotte Cnops et al. · 2019 · Vaccines
  42. Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
    Zhan Zhang, Qi Shen, Haocai Chang · 2022 · Frontiers in Immunology
  43. A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs
    Bram Bogaert, Félix Sauvage, Roberta Guagliardo, Cristina Muntean, Van Phuc Nguyen, Eline Pottie, Mike Wels, An‐Katrien Minnaert, Riet Maria De Rycke, Qiangbing Yang et al. · 2022 · Journal of Controlled Release
  44. The Delivery of mRNA Vaccines for Therapeutics
    Nitika, Jiao Wei, Ai‐Min Hui · 2022 · Life
  45. Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?
    Akbar Hasanzadeh, Michael Richard Hamblin, Jafar Kiani, Hamid Noori, Joseph Michael Hardie, Mahdi Karimi, Hadi Shafiee · 2022 · Nano Today
  46. Future Trends in Nebulized Therapies for Pulmonary Disease
    Sean McCarthy, Héctor E. González, Brendan D. Higgins · 2020 · Journal of Personalized Medicine
  47. Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics
    Jacob W. Coffey, Gaurav D. Gaiha, Giovanni Traverso · 2020 · The Annual Review of Pharmacology and Toxicology
  48. The Ugi Three‐Component Reaction; a Valuable Tool in Modern Organic Synthesis
    Nikolaos P. Tripolitsiotis, Maria Thomaidi, Constantinos G. Neochoritis · 2020 · European Journal of Organic Chemistry
  49. Cardiovascular and haematological events post COVID‐19 vaccination: A systematic review
    Dana Al‐Ali, Abdallah Elshafeey, Malik Mushannen, Hussam Kawas, Ameena Shafiq, Narjis Mhaimeed, Omar Mhaimeed, Nada Mhaimeed, Rached Zeghlache, Mohammad A. Salameh et al. · 2021 · Journal of Cellular and Molecular Medicine
  50. Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
    Ziqi Wang, Kai Cui, Ulrich Costabel, Xiaoju Zhang · 2022 · Exploration
  51. A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19
    Michael Mörz · 2022 · Vaccines
  52. Delivering mRNA to Secondary Lymphoid Tissues by Phosphatidylserine‐Loaded Lipid Nanoparticles
    Masaki Gomi, Yu Sakurai, Minami Sato, Hiroki Tanaka, Yumi Miyatake, Koichi Fujiwara, Mizuki Watanabe, Satoshi Shuto, Yuta Nakai, Kota Tange et al. · 2022 · Advanced Healthcare Materials
  53. mRNA: A promising platform for cancer immunotherapy
    Byoungjae Kong, Yelee Kim, Eun Hye Kim, Jung Soo Suk, Yoosoo Yang · 2023 · Advanced Drug Delivery Reviews
  54. RNA Therapeutics for the Cardiovascular System
    Victor J. Dzau, Conrad P. Hodgkinson · 2024 · Circulation
  55. An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial
    Saraf, Amit, Gurjar, Rohan, Kaviraj, Swarnendu, Kulkarni, Aishwarya, Kumar, Durgesh, Kulkarni, Ruta, Virkar, Rashmi, Krishnan, Jayashri, Yadav, Anjali, Baranwal, Ekta et al. · 2024 · Nature Medicine
  56. An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
    Kevin P. Egan, Lauren M. Hook, Alexis M. Naughton, Norbert Pardi, Sita Awasthi, Gary H. Cohen, Drew Weissman, Harvey M. Friedman · 2020 · PLoS Pathogens
  57. Polymer–Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies
    Sabrina Bochicchio, Gaetano Lamberti, Anna Angela Barba · 2021 · Pharmaceutics
  58. One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection
    Ruikang Liu, Jeffrey L. Americo, Catherine A. Cotter, Patricia L. Earl, Noam Erez A, Chen Peng, Bernard Moss · 2021 · Proceedings of the National Academy of Sciences
  59. Perspectives on RNA Vaccine Candidates for COVID-19
    Pobitra Borah, Pran Kishore Deb, Nizar A. Al‐Shar’i, Lina A. Dahabiyeh, Katharigatta Narayanaswamy Venugopala, Vinayak Singh, Pottathil Shinu, Snawar Hussain, Satyendra Deka, Balakumar Chandrasekaran et al. · 2021 · Frontiers in Molecular Biosciences
  60. Safety and Immunogenicity of a Messenger RNA–Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1 Randomized Clinical Trial
    Carlos A. Fierro, Daniel Brune, Marian Shaw, Howard Schwartz, Conor Knightly, Jiang Lin, Andrea Carfı́, Andrew Natenshon, Shiva Kalidindi, Caroline Bouteiller-Reuter et al. · 2024 · The Journal of Infectious Diseases
  61. Toward microfluidic continuous-flow and intelligent downstream processing of biopharmaceuticals
    Vikas Sharma, Amirreza Mottafegh, Jeong‐Un Joo, Jiho Kang, Lei Wang, Dong‐Pyo Kim · 2024 · Lab on a Chip
  62. Advances in metal ion–mediated macromolecular drug delivery
    Ke Li, Jieru Yang, Ying Peng, Huiwen Zheng, Zhi-Zhan Fu, Meiying Li, Wenhu Zhou, Guofeng Yu · 2025 · International Journal of Pharmaceutics
  63. Adjuvant incorporated lipid nanoparticles for enhanced mRNA-mediated cancer immunotherapy
    Kyuri Lee, Soo Young Kim, Yunmi Seo, Myung Hee Kim, Jun Chang, Hyukjin Lee · 2019 · Biomaterials Science
  64. Automated high-throughput preparation and characterization of oligonucleotide-loaded lipid nanoparticles
    Yuchen Fan, Chun‐Wan Yen, Hsiu-Chao Lin, Weijia Hou, Alberto Estevez, Apoorva Sarode, Alexandre Goyon, Juan Bian, Jessica Lin, Stefan G. Koenig et al. · 2021 · International Journal of Pharmaceutics
  65. Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies
    Sodiq Ayobami Hameed, Stéphane Paul, Giann Kerwin Y. Dellosa, Dolores Jaraquemada, Muhammad Bashir Bello · 2022 · npj Vaccines
  66. Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized mice
    Eleonora Melzi, Jordan R. Willis, Krystal M. Ma, Ying‐Cing Lin, Sven Kratochvil, Zachary T. Berndsen, Elise Landais, Oleksandr Kalyuzhniy, Usha Nair, John E. Warner et al. · 2022 · Immunity
  67. Advanced delivery systems for peptide antibiotics
    Angela Cesaro, Shuang‐Zhe Lin, Norbert Pardi, César de la Fuente‐Núñez · 2023 · Advanced Drug Delivery Reviews
  68. An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines
    Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, Shokouh Rezaei, Vuk Uskoković, Mahdi Alijanianzadeh, Vladimir Nikolaevich Uversky, Seyed Omid Ranaei Siadat, Sina Mozaffari‐Jovin, Yahya Sefidbakht · 2023 · Progress in Biophysics and Molecular Biology
  69. Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines
    Colin A. Russell, Ron A. M. Fouchier, Parinaz K. Ghaswalla, Yoonyoung Park, Nevena Vicic, Jintanat Ananworanich, Raffael Nachbagauer, Deborah Rudin · 2024 · Human Vaccines & Immunotherapeutics
  70. pH‐Responsive β‐Glucans‐Complexed mRNA in LNPs as an Oral Vaccine for Enhancing Cancer Immunotherapy
    Po-Kai Luo, Hui‐Min Ho, Min‐Chun Chiang, Li‐An Chu, Ya‐Han Chuang, Pingchiang C. Lyu, I‐Chen Hu, Wan-An Chang, Sheng‐Yao Peng, Jayachandran Jayakumar et al. · 2024 · Advanced Materials
  71. Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters
    Michael K. Lo, Jessica R. Spengler, Stephen R. Welch, Jessica R. Harmon, JoAnn D. Coleman-McCray, Florine E. M. Scholte, Punya Shrivastava-Ranjan, Joel M. Montgomery, Stuart T. Nichol, Drew Weissman et al. · 2019 · The Journal of Infectious Diseases
  72. Targeting aging and age-related diseases with vaccines
    Wu, Ruochen, Sun, Fei, Zhang, Weiqi, Ren, Jie, Liu, Guang-Hui · 2024 · Nature Aging
  73. Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy
    Christian G. Figueroa‐Espada, Samuel I. Hofbauer, Michael J. Mitchell, Rachel Riley · 2020 · Advanced Drug Delivery Reviews
  74. Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
    Dániel Szõke, Gábor Kovács, Éva Kemecsei, László Bálint, Kitti Ajtay, Petra Aradi, Andrea Styevkóné Dinnyés, Barbara L. Mui, Ying K. Tam, Thomas D. Madden et al. · 2021 · Nature Communications
  75. Current understandings and clinical translation of nanomedicines for breast cancer therapy
    Yike Jiang, Ziyi Jiang, Mingzhe Wang, Lan Ma · 2021 · Advanced Drug Delivery Reviews
  76. Ising-CIM: A Reconfigurable and Scalable Compute Within Memory Analog Ising Accelerator for Solving Combinatorial Optimization Problems
    Shanshan Xie, Siddhartha Raman Sundara Raman, Can Ni, Meizhi Wang, Mengtian Yang, Jaydeep P. Kulkarni · 2022 · IEEE Journal of Solid-State Circuits
  77. Supramolecular Lipid Nanoparticles Based on Host–Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy
    Shaolong Qi, Xueyan Zhang, Xinyang Yu, Lulu Jin, Kai Yang, Yangfan Wang, Yunxuan Feng, Jiaqi Lei, Zhengwei Mao, Guocan Yu · 2024 · Advanced Materials
  78. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice
    Samsa, Marcelo M., Dupuy, Lesley C., Beard, Clayton W., Six, Carolyn M., Schmaljohn, Connie S., Mason, Peter W., Geall, Andrew J., Ulmer, Jeffrey B., Yu, Dong · 2019 · Molecular Therapy
  79. Biopolymer‐based Carriers for DNA Vaccine Design
    Christoph O. Franck, Luise Fanslau, Andrea Bistrović, Puneet Tyagi, Ljiljana Fruk · 2020 · Angewandte Chemie International Edition
  80. Therapeutic RNA Delivery for COVID and Other Diseases
    Curtis N. Dobrowolski, Kalina Paunovska, Marine Z. C. Hatit, Melissa P. Lokugamage, James E. Dahlman · 2021 · Advanced Healthcare Materials
  81. Review of COVID-19 Vaccines Approved in the United States of America for Emergency Use
    Deepa Vasireddy, Paavani Atluri, Srikrishna Varun Malayala, Rachana Vanaparthy, Gisha Mohan · 2021 · Journal of Clinical Medicine Research
  82. The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2
    Hai Huang, Caili Zhang, Shuping Yang, Wen Xiao, Qian Zheng, Xiangrong Song · 2021 · Journal of Controlled Release
  83. Therapeutic cancer vaccines revamping: technology advancements and pitfalls
    Gabriele Antonarelli, Chiara Corti, Paolo Tarantino, Liliana Ascione, Javier Cortés, Pedro J. Romero, EA Mittendorf, Mary Lenora Disis, Giuseppe Curigliano · 2021 · Annals of Oncology
  84. Immune Escape Mechanism and Vaccine Research Progress of African Swine Fever Virus
    Zhaoyang Wang, Qiangyun Ai, Shenglin Huang, Yating Ou, Yinze Gao, Tiezhu Tong, Huiying Fan · 2022 · Vaccines
  85. Delivery of mRNA for regulating functions of immune cells
    Jia Yu Shi, Mengwen Huang, Zi-Dong Lu, Xiao‐Jiao Du, Song Shen, Cong‐Fei Xu, Jun Wang · 2022 · Journal of Controlled Release
  86. Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
    Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, Vasso Apostolopoulos, Chirag Amrutlal Patel, Rajashri Bezbaruah, Aayushi Patel, Zhe‐Sheng Chen · 2022 · Frontiers in Immunology
  87. Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines
    Junyan Li, Yuanyuan Wu, Jian Xiang, Hairong Wang, Qi Zhuang, Ting Wei, Zhiqin Cao, Qingyang Gu, Zhuang Liu, Rui Peng · 2022 · Chemical Engineering Journal
  88. The role of vaccines in the COVID-19 pandemic: what have we learned?
    Florian Krammer · 2023 · Seminars in Immunopathology
  89. Cancer vaccines: Target antigens, vaccine platforms and preclinical models
    Francesca Ruzzi, Federica Riccardo, Laura Conti, Lidia Tarone, Maria Sofia Semprini, Elisabetta Bolli, Giuseppina Barutello, Elena Quaglino, Pier‐Luigi Lollini, Federica Cavallo · 2024 · Molecular Aspects of Medicine
  90. Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation
    Yunxuan Feng, Wanbo Tai, Pei Huang, Shaolong Qi, Xinyang Yu, Mengfei Li, Mengyao Li, Miya Zhang, Fangfang Cao, Xiaomin Gao et al. · 2025 · Nature Materials
  91. Advances in RNA-based therapeutics: current breakthroughs, clinical translation, and future perspectives
    Sarbjeet Kaur Makkar · 2025 · Frontiers in Genetics
  92. In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
    Lucas Michel Todó, Pedro Antonio Reche, Pascal Bigey, María‐Jesús Pinazo, Joaquím Gascón, Julio Alonso-Padilla · 2019 · Frontiers in Immunology
  93. Prophylactic Cancer Vaccines Engineered to Elicit Specific Adaptive Immune Response
    Davis W. Crews, Jenna A. Dombroski, Michael R. King · 2021 · Frontiers in Oncology
  94. A review on the advances and challenges of immunotherapy for head and neck cancer
    Gang Cheng, Hui Dong, Chen Yang, Liu Yang, Yi Wu, Lifen Zhu, Xiangmin Tong, Shibing Wang · 2021 · Cancer Cell International
  95. A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19
    Essa M. Saied, Yousra A. El‐Maradny, Alaa A. Osman, Amira M.G. Darwish, Hebatallah H. Abo Nahas, Gniewko Niedbała, Magdalena Piekutowska, Mohamed A. Abdel-Rahman, Bassem A. Balbool, Ahmed M. Abdel-Azeem · 2021 · Pharmaceutics
  96. Antisense Oligonucleotide-Based Therapy of Viral Infections
    Woan‐Yuh Tarn, Yun Cheng, Shih-Han Ko, Li‐Min Huang · 2021 · Pharmaceutics
  97. Nanoparticle-based delivery strategies of multifaceted immunomodulatory RNA for cancer immunotherapy
    Yeon Jeong Yoo, Chang Hoon Lee, Sei Hyun Park, Yong Taik Lim · 2022 · Journal of Controlled Release
  98. A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets
    Koen van de Ven, Josien Lanfermeijer, Harry van Dijken, Hiromi Muramatsu, Caroline Vilas Boas de Melo, Stefanie Lenz, Florence Peters, Mitchell B. Beattie, Paulo J.C. Lin, José A. Ferreira et al. · 2022 · Science Advances
  99. Get out or die trying: Peptide- and protein-based endosomal escape of RNA therapeutics
    A. Klipp, Michael Burger, Jean‐Christophe Leroux · 2023 · Advanced Drug Delivery Reviews
  100. Big data and deep learning for RNA biology
    Hyeonseo Hwang, Hyeonseong Jeon, Nagyeong Yeo, Daehyun Baek · 2024 · Experimental & Molecular Medicine